SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-104983
Filing Date
2024-10-01
Accepted
2024-10-01 16:53:00
Documents
1
Group Members
DANIEL MACKWILMOT B. HARKEY

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2425294d1_sc13da.htm SC 13D/A 64558
  Complete submission text file 0001104659-24-104983.txt   66219
Mailing Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Subject) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87872 | Film No.: 241344065
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840
Business Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840 203-404-1172
Nantahala Capital Management, LLC (Filed by) CIK: 0001472322 (see all company filings)

IRS No.: 201151760 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13D/A